REUTERS
September 25, 2025 at 11:50 JST
Tylenol is displayed for sale at a pharmacy in New York City, New York, U.S., September 5, 2025. (REUTERS)
SEOUL--South Korea’s drug watchdog said on Tuesday it would seek information from relevant companies after U.S. President Donald Trump linked the use of Tylenol by pregnant women to autism, a claim that is unsupported by scientific evidence.
The drug regulator said it would review the opinions and documents provided by the companies.
On Monday, Trump also linked autism to childhood vaccine use.
“Since the U.S. government’s announcement contained little substance, we have no additional comments,” South Korea’s food and drug safety ministry said on Wednesday.
“However, we plan to request relevant papers and data from paracetamol importers and manufacturers.”
After Trump linked paracetamol to autism, international health agencies reaffirmed it was safe to use during pregnancy.
The World Health Organization said there was no conclusive scientific evidence linking paracetamol use during pregnancy to autism.
The European Medicines Agency said available evidence had found no such link and advised use of the lowest effective doses of the drug according to the frequency needed.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series about Japanese-Americans and their memories of World War II
